IL3RA and acute myeloid leukemia: In recent years, the IL-3 receptor system has come under the spotlight because stem/progenitor cells from patients with acute myeloid leukaemia (AML) overexpress the IL-3 receptor α-subunit (IL3Rα) and this is associated with reduced patient survival3,6–9.